Authors
»
Chow, Ka Ming -More
Category
»
Primary study
Registry of Trials»ISRCTN registry
Year
»
2023
INTERVENTION: Each participant will be randomly assigned to either an intervention group or a control group in a 1:1 ratio using block randomisation. Participants in the intervention group will receive a 12‐week multimodal cancer rehabilitation intervention (MCRI), in which they will be granted access to an enhanced version of the Women's Wellness After Cancer Programme (WWACPHK) developed by our research team via a mobile‐enabled platform and three virtual counselling sessions. The 12‐week programme will cover topics such as healthy diet, exercise, menopause‐related symptoms and management, sleep, sexuality, body image, pelvic floor exercises, stress management, chronic disease prevention and cancer screening. For the WWACPHK app, new information and evidence will be posted on the app every day in the first three weeks, and then weekly for the following nine weeks. A research nurse will monitor the number of modules accessed and conduct reminder telephone calls when an account is inactive for a week or more to enhance adherence. Furthermore, three individual virtual counselling sessions with the research nurse will be scheduled at weeks 1, 6 and 12 to (i) empower the participants by providing guidance on the use of the digital platform and the needed health information; and (ii) engage the participants to reflect on their belief, assumptions, knowledge and goals. Participants in the control group will receive brief information on the follow‐up schedule during baseline data collection. To control for the attention effect, participants will receive attention from the research nurse on three occasions in the same period of time as the intervention group. The nurse will make telephone calls to them at weeks 1, 6 and 12 to deliver general greetings and CONDITION: Women treated for gynaecological cancer ; Cancer PRIMARY OUTCOME: Sense of coherence measured using the Chinese version of the Sense of Coherence 13‐item Scale (CSOC‐13) at baseline, completion of the intervention, and 12 weeks after completion INCLUSION CRITERIA: 1. Women with a primary diagnosis of gynaecological cancers (uterine, ovarian or cervical cancers) 2. Within 3 months of completion of intensive cancer treatments (e.g. surgery, radiotherapy, and /or chemotherapy) 3. Over 18 years old 4. Able to understand spoken Cantonese and to read Chinese 5. Having smartphones with iOS or Android operating systems 6. Consenting to participate SECONDARY OUTCOME: ; 1. Cancer‐specific distress measured using the Chinese version of the Impact of Events‐Revised scale (CIES‐R) at baseline, completion of the intervention, and 12 weeks after completion; 2. Dietary and physical activity practices measured using the Chinese version of Health Promotion Lifestyle Profile II (HPLP‐II) at baseline, completion of the intervention, and 12 weeks after completion; 3. Health‐related quality of life measured using the Chinese version of the Medical Outcomes Study (MOS) 36‐item Short Form (SF‐36) Health Survey at baseline, completion of the intervention, and 12 weeks after completion; 4. Health‐related quality of life measured using the Hong Kong version of the five‐level EuroQol‐5 Dimension (EQ‐5D‐5L) every three months from baseline to 12‐month post‐intervention; 5. Participants' experiences, perceptions and opinions explored by semi‐structured interviews upon completion of the intervention;
Epistemonikos ID: 92a89a7762d65f3ad7f00548664fab2551b649a9
First added on: Aug 26, 2024